Innatoss Laboratories Launches Neutralizing Antibody Public Te... - 15 September 2020 19:52

LEIDEN, Netherlands and OSS, Netherlands and PISCATAWAY, New Jersey,Sept. 15, 2020/PRNew cPass is first commercially available product to rapidly detect neutralizing antibodies capable of eliminating virus Innatoss Laboratories(https://www.innatoss.com/en/) announced today the first neutralizing antibody testing service against S...

  MAGHREB PHARMA Expo to contribute to Algeria plans to export f... - 15 September 2020 16:00

ALGIERS, Algeria, September 15, 2020, /PRNewswire-AsiaNet/-- Easyfairs Northeral, the organizer of MAGHREB PHARMA Expo has announced new dates for its annual international tradeshow for the pharmaceutical industry in North Africa. In this context, the Algerian Pharmaceutical Industry Minister, Lotfi Benbahm...

  Introducing DuPont(TM) Liveo(TM) for healthcare silicone solut... - 15 September 2020 10:00

WILMINGTON, Del., Sept. 15, 2020 /PRNewswire-AsiaNet/ -- DuPont (NYSE: DD), a globally recognized leader in silicone-based technology with more than 70 years of experience advancing healthcare through materials innovation, is introducing DuPont™ Liveo™, a new brand name for its extensive range of silico...

  Concept Medical announces index patient enrolment in world's f... - 15 September 2020 01:10

SINGAPORE, Sept. 14, 2020 /PRNewswire/ AsiaNet/ -- Concept Medical Inc.[https://www.conceptmedical.com/], focused on vascular intervention drug delivery devices, has announced the enrolment of the first patient in the FUTURE SFA (Randomized Controlled Trial of First SirolimUs CoaTed Balloon Ve...

  Seelos Announces Issuance of a New Patent and an Additional No... - 14 September 2020 23:00

NEW YORK, Sept. 14, 2020 /PRNewswire-AsiaNet/ -- - Patents Further Strengthen Global Intellectual Property Portfolio in Psychiatry Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders...

  Merck Advances Oncology Portfolio and Pipeline with New and Lo... - 14 September 2020 08:05

DARMSTADT, Germany, Sept. 14, 2020 /PRNewswire-AsiaNet/ -- - New analyses from Phase III JAVELIN Bladder 100 study of BAVENCIO(R)* assess efficacy across subgroups, patient-reported outcomes and exploratory biomarkers in advanced urothelial cancer - Overall efficacy data, and analyses of brain metastas...

  Global Fund Partnership Has Saved 38 Million Lives – but COVID... - 14 September 2020 08:01

GENEVA, Sept. 14, 2020 /PRNewswire-AsiaNet/ -- A new report by the Global Fund to Fight AIDS, Tuberculosis and Malaria is a call to action to urgently invest to protect decades of progress against HIV, TB and malaria that are being derailed as a knock-on effect of the COVID-19 pandemic. Acc...

  Haoma Medica Announces Plenary Presentation for NaQuinate, a P... - 12 September 2020 07:00

LONDON, September 12, 2020, /PRNewswire-AsiaNet/-- Haoma Medica announced a presentation made today at the 2020 American Society for Bone and Mineral Research: Dr Andrew Pitsillides, Professor of Skeletal Dynamics at the Royal Veterinary College, London presented 'NaQuinate: A Drug that Selecti...

  New MAVENCLAD (R) Data at ACTRIMS-ECTRIMS MSVirtual2020 Meetin... - 11 September 2020 22:00

DARMSTADT, Germany, September 11, 2020, /PRNewswire-AsiaNet/-- In MAGNIFY-MS, patients experienced a rapid onset of action from end of Month 1 that was significant in all study periods versus baseline Post-approval safety analysis showed no increased risk of viral respiratory infections and lower rates of...

  Sai Life Sciences expands suite of cellular analysis platforms... - 11 September 2020 13:30

CAMBRIDGE, Mass. and HYDERABAD, India, Sept. 11, 2020 /PRNewswire/ AsiaNet/ -- Sai Life Sciences, one of India's fastest growing Contract Development & Manufacturing Organizations (CDMOs)[ https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=cambridge-cellular-analysis-platforms], today announced the additi...